Physician profile
Benjamin D Prohaska
NPI 1174652143
$30,701.27
in general payments reported to CMS, 2019-2025
40 companies · $4,464 in 2025
The $4,464 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,110 · 2022: $5,976 · 2023: $12K · 2024: $4,005 · 2025: $4,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,690 · Consulting Fee: $4,915 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,250 · Travel and Lodging: $1,818 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $910 · Education: $32.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,689.54 |
| Consulting Fee | $4,915.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,250.00 |
| Travel and Lodging | $1,817.86 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $910.00 |
| Education | $32.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $9,765.75 | 2021-2025 | Afrezza |
| Sanofi-Aventis U.S. LLC | $5,274.12 | 2021-2025 | |
| Novo Nordisk INC | $4,271.57 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Corcept Therapeutics | $2,524.10 | 2021-2025 | Korlym |
| Lilly USA, LLC | $1,380.65 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,043.43 | 2021-2025 | Jardiance, Synjardy |
| Xeris Pharmaceuticals, INC. | $850.38 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $808.04 | 2021-2025 | Minimed 780g, Simplera Sensor, Intellis Adaptivestim |
| Amgen INC. | $574.87 | 2021-2025 | Tepezza, Evenity, Repatha |
| Astrazeneca Pharmaceuticals LP | $554.67 | 2021-2022 | |
| Abbott Laboratories | $516.85 | 2021-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $389.20 | 2021-2024 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $383.79 | 2021-2025 | |
| Insulet Corporation | $312.62 | 2022-2025 | Omnipod |
| Recordati_rare_diseases_inc. | $300.91 | 2021-2025 | Isturisa, Signifor Lar |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $285.06 | 2022-2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $188.31 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $147.15 | 2021-2024 | Strensiq |
| Antares Pharma, INC. | $138.81 | 2022-2025 | Xyosted |
| Horizon Therapeutics Plc | $104.20 | 2022-2023 | Tepezza |
| Verity Pharmaceuticals INC. | $95.08 | 2025 | Tlando |
| Novartis Pharmaceuticals Corporation | $90.32 | 2023-2024 | |
| Ibsa Pharma INC. | $86.90 | 2021 | |
| Tandem Diabetes Care, INC. | $85.77 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Amarin Pharma, INC. | $79.57 | 2021 | |
| Beta Bionics, INC. | $76.62 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ascensia Diabetes Care US INC. | $57.08 | 2023-2025 | |
| Esperion Therapeutics, INC. | $37.95 | 2022 | |
| Alfasigma USA, INC. | $34.62 | 2021-2022 | |
| Zealand Pharma US, INC. | $34.14 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $27.51 | 2022 | |
| Alnylam Pharmaceuticals INC. | $26.68 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $23.20 | 2023 | Inpefa |
| Clarus Therapeutics INC. | $23.07 | 2021 | |
| Rgh Enterprises LLC | $22.20 | 2025 | |
| Nevro Corp. | $19.33 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $18.30 | 2021 | |
| Averitas Pharma INC. | $17.62 | 2023 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $16.98 | 2022 | |
| Grt US Holding, INC. | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Prohaska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.